Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | VCAN |
| Upstream (Parents) |
|---|
| (<<) HLA-DRA → VCAN |
| (<<) FBN1 → VCAN |
| (<<) DCN → VCAN |
| (<<) MFAP2 → VCAN |
| Downstream (Children) |
|---|
| VCAN → INSRR (>>) |
| VCAN → CDH11 (>>) |
| VCAN → KIAA1033 (>>) |
| VCAN → CYP1A2 (>>) |
| VCAN → ENPEP (>>) |
| VCAN → GULP1 (>>) |
| VCAN → PLXNC1 (>>) |
| VCAN → EPB41L2 (>>) |
| VCAN → TNP2 (>>) |
| VCAN → CDKN2A (>>) |
| VCAN → ADAM29 (>>) |
| VCAN → MNX1 (>>) |
| VCAN → ZEB1 (>>) |
| VCAN → RBMY1J///RBMY1E///RBMY1D///RBMY1B///RBMY1F///RBMY3AP///RBMY1H///RBMY1A1 (>>) |
| VCAN → TRBV10-2 (>>) |
| VCAN → ZHX3 (>>) |
| VCAN → MTMR8 (>>) |
| VCAN → FAM174B (>>) |
| VCAN → DYRK2 (>>) |
| VCAN → RAB23 (>>) |
| VCAN → C2orf67 (>>) |
